ornibel 0.12 mg/24 timer / 0.015 mg/24 timer
exeltis healthcare s.l. - etonogestrel / etinyløstradiol - vaginalinnlegg - 0.12 mg/24 timer / 0.015 mg/24 timer
mirabella 100 mikrog / 20 mikrog
exeltis healthcare s.l. - levonorgestrel / etinyløstradiol - tablett, filmdrasjert - 100 mikrog / 20 mikrog
topimax 15 mg
janssen-cilag as - topiramat - kapsel, hard - 15 mg
topimax 25 mg
janssen-cilag as - topiramat - kapsel, hard - 25 mg
topimax 25 mg
janssen-cilag as - topiramat - tablett, filmdrasjert - 25 mg
topimax 50 mg
janssen-cilag as - topiramat - tablett, filmdrasjert - 50 mg
topimax 100 mg
janssen-cilag as - topiramat - tablett, filmdrasjert - 100 mg
topimax 200 mg
janssen-cilag as - topiramat - tablett, filmdrasjert - 200 mg
yana 2 mg / 0.03 mg
heaton k.s - dienogest / etinyløstradiol - tablett, filmdrasjert - 2 mg / 0.03 mg
braftovi
pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - antineoplastiske midler - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy.